Prof Marco Cattaneo speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about regulatory mechanisms of platelet activation and inhibition.

Prof Cattaneo explains the implications of the science behind platelet activation and inhibition for current treatment and future clinical research.

He concludes that, based on this research, it is likely that patients could be given lower doses of aspirin - meaning that they would experience fewer side effects.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.